Skip to main content
. 2021 Oct 2;20:61–64. doi: 10.1016/j.jdcr.2021.09.030

Fig 1.

Fig 1

Clinical images of patients 1 and 3 before and after tofacitinib treatment for cutaneous lupus erythematosus.